hematologic diseases
Conditions
Interventions
None listed
Sponsors
KSGCT
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: all patients who receive HCT for the first time
Exclusion criteria
Exclusion criteria: patients who receive second HCT
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| non-relapse mortality and overall survival | — |
Countries
Japan
Contacts
Public ContactAya Nakaya
Keio University School of Medicine Division of Hematology
Outcome results
None listed